Clearpoint Neuro, Inc. (CLPT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157143,
    "name": "Clearpoint Neuro, Inc.",
    "stock_name": "Clearpoint Neuro, Inc.",
    "full_name": "Clearpoint Neuro, Inc.",
    "name_url": "stocks-analysis/clearpoint-neuro-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "14.06",
    "chg": 0.72,
    "chgp": "5.4%",
    "dir": 1,
    "prev_price": "13.34",
    "mcapval": "310.71",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US18507C1036",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "313.77 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/clearpoint-neuro-inc-1157143-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Clearpoint Neuro Stock Forms Golden Cross, Signals Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-stock-forms-golden-cross-signals-bullish-breakout-ahead-3617254",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ClearpointNeuro_goldencross_3617254.png",
        "date": "2025-10-10 19:13:53",
        "description": "Clearpoint Neuro, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500 significantly over the past year and year-to-date. Despite a minor decline today, its weekly performance remains strong, supported by positive technical indicators."
      },
      {
        "title": "Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-inc-hits-new-52-week-high-of-2985-3608038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ClearpointNeuro_priceRelatedfactors_3608038.png",
        "date": "2025-10-09 20:19:28",
        "description": "Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 29.85, reflecting a remarkable 415.68% increase over the past year. With a market capitalization of USD 311 million, the company operates in a competitive biotechnology sector, showcasing significant growth potential despite challenging financial metrics."
      },
      {
        "title": "Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-reaches-new-52-week-high-of-2880-up-377-3595656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ClearpointNeuro_priceRelatedfactors_3595656.png",
        "date": "2025-10-06 17:38:03",
        "description": "Clearpoint Neuro, Inc. has achieved a new 52-week high, reflecting a significant year-over-year stock performance increase. With a market capitalization of USD 311 million, the company operates at a loss, indicated by its negative price-to-earnings ratio. This milestone emphasizes the volatility and potential in the biotechnology sector."
      },
      {
        "title": "Clearpoint Neuro, Inc. Hits New 52-Week High of $22.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-inc-hits-new-52-week-high-of-2238-3586058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ClearpointNeuro_priceRelatedfactors_3586058.png",
        "date": "2025-10-01 16:41:25",
        "description": "Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 22.38, marking a substantial increase over the past year. With a market capitalization of USD 311 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, amidst a competitive biotechnology landscape."
      },
      {
        "title": "Clearpoint Neuro Hits New 52-Week High of $21.76, Up 275% Yearly",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-hits-new-52-week-high-of-2176-up-275-yearly-3579376",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearpointNeuro_priceRelatedfactors_3579376.png",
        "date": "2025-09-29 14:27:39",
        "description": "Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 21.76, reflecting a significant increase over the past year. With a market capitalization of USD 311 million, the company operates in a competitive biotechnology sector, despite facing challenges such as negative return on equity and a high price-to-book ratio."
      },
      {
        "title": "Clearpoint Neuro Hits New 52-Week High of $21.57, Up 243.9%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-hits-new-52-week-high-of-2157-up-2439-3574500",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearpointNeuro_priceRelatedfactors_3574500.png",
        "date": "2025-09-26 15:13:30",
        "description": "Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 21.57, reflecting a notable increase of 243.9% over the past year. With a market capitalization of USD 311 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, amidst a competitive biotechnology landscape."
      },
      {
        "title": "Clearpoint Neuro Reaches New 52-Week High of $20.94, Up 235.89%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/clearpoint-neuro-reaches-new-52-week-high-of-2094-up-23589-3571341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ClearpointNeuro_priceRelatedfactors_3571341.png",
        "date": "2025-09-25 16:48:25",
        "description": "Clearpoint Neuro, Inc. has achieved a new 52-week high, reflecting a significant increase over the past year. With a market capitalization of USD 311 million, the company operates in a competitive biotechnology sector but is currently not profitable, as indicated by its negative return on equity."
      },
      {
        "title": "Is Clearpoint Neuro, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-clearpoint-neuro-inc-technically-bullish-or-bearish-3547355",
        "imagepath": "",
        "date": "2025-09-20 19:53:30",
        "description": "As of 12 September 2025, the technical trend for Clearpoint Neuro, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the weekly MACD being mildly bullish while the monthly MACD is mildly bearish. The daily moving averages are also mildly bearish, and the KST shows bearish signals on the weekly timeframe. The OBV is bearish on both weekly and monthly charts. \n\nIn terms of performance, Clearpoint Neuro has underperformed the S&P 500 significantly year-to-date, with a return of -26.20% compared to the S&P 500's 12.22%. Over the past year, it has also lagged behind, returning -2.66% versus the S&P 500's 17.14%...."
      }
    ],
    "total": 12,
    "sid": "1157143",
    "stock_news_url": "https://www.marketsmojo.com/news/clearpoint-neuro-inc-1157143"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Clearpoint Neuro Stock Forms Golden Cross, Signals Bullish Breakout Ahead

2025-10-10 19:13:53

Clearpoint Neuro, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500 significantly over the past year and year-to-date. Despite a minor decline today, its weekly performance remains strong, supported by positive technical indicators.

Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85

2025-10-09 20:19:28

Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 29.85, reflecting a remarkable 415.68% increase over the past year. With a market capitalization of USD 311 million, the company operates in a competitive biotechnology sector, showcasing significant growth potential despite challenging financial metrics.

Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377%

2025-10-06 17:38:03

Clearpoint Neuro, Inc. has achieved a new 52-week high, reflecting a significant year-over-year stock performance increase. With a market capitalization of USD 311 million, the company operates at a loss, indicated by its negative price-to-earnings ratio. This milestone emphasizes the volatility and potential in the biotechnology sector.

Clearpoint Neuro, Inc. Hits New 52-Week High of $22.38

2025-10-01 16:41:25

Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 22.38, marking a substantial increase over the past year. With a market capitalization of USD 311 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, amidst a competitive biotechnology landscape.

Clearpoint Neuro Hits New 52-Week High of $21.76, Up 275% Yearly

2025-09-29 14:27:39

Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 21.76, reflecting a significant increase over the past year. With a market capitalization of USD 311 million, the company operates in a competitive biotechnology sector, despite facing challenges such as negative return on equity and a high price-to-book ratio.

Clearpoint Neuro Hits New 52-Week High of $21.57, Up 243.9%

2025-09-26 15:13:30

Clearpoint Neuro, Inc. has achieved a new 52-week high of USD 21.57, reflecting a notable increase of 243.9% over the past year. With a market capitalization of USD 311 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, amidst a competitive biotechnology landscape.

Clearpoint Neuro Reaches New 52-Week High of $20.94, Up 235.89%

2025-09-25 16:48:25

Clearpoint Neuro, Inc. has achieved a new 52-week high, reflecting a significant increase over the past year. With a market capitalization of USD 311 million, the company operates in a competitive biotechnology sector but is currently not profitable, as indicated by its negative return on equity.

Is Clearpoint Neuro, Inc. technically bullish or bearish?

2025-09-20 19:53:30

As of 12 September 2025, the technical trend for Clearpoint Neuro, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the weekly MACD being mildly bullish while the monthly MACD is mildly bearish. The daily moving averages are also mildly bearish, and the KST shows bearish signals on the weekly timeframe. The OBV is bearish on both weekly and monthly charts. In terms of performance, Clearpoint Neuro has underperformed the S&P 500 significantly year-to-date, with a return of -26.20% compared to the S&P 500's 12.22%. Over the past year, it has also lagged behind, returning -2.66% versus the S&P 500's 17.14%....

View All News